Physician profile
Emily Kachelmeyer
NPI 1396466991
$7,476.63
in general payments reported to CMS, 2019-2025
42 companies · $3,171 in 2025
The $3,171 reported for 2025 was more than what 97% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2023: $1,334 · 2024: $2,852 · 2025: $3,171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,356.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $885.49 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Xeris Pharmaceuticals, INC. | $734.56 | 2023-2025 | Recorlev, Gvoke Hypopen, Keveyis |
| Insulet Corporation | $613.82 | 2024-2025 | Omnipod |
| Amgen INC. | $582.35 | 2023-2025 | Tepezza, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $530.71 | 2023-2025 | |
| Novo Nordisk INC | $469.15 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $418.16 | 2023-2025 | Korlym |
| Dexcom, INC. | $332.76 | 2023-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Cequr Corporation | $238.41 | 2024-2025 | Cequr Simplicity |
| Astellas Pharma US INC | $229.72 | 2024-2025 | Veozah |
| Recordati_rare_diseases_inc. | $226.03 | 2024-2025 | Isturisa, Signifor Lar |
| Tandem Diabetes Care, INC. | $201.20 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $194.35 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Medtronic, INC. | $182.42 | 2023-2025 | Minimed 780g |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $152.06 | 2022-2023 | Lifevest |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Kachelmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.